Ending The Global Tuberculosis Epidemic: The Role Of Patient Costs
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
TB is an important public health problem worldwide. Rates of TB are declining but not fast enough to reach targets set by the World Health Organization to end the disease by 2035. One reason why TB remains an issue is the cost of health care for patients. My research will look at the costs of TB care for patients in Papua New Guinea and will compare costs between countries. I will look at policies to protect the sick and will conduct research to determine what works best in decreasing costs.
My work focuses on the prevention of vascular disease. A major aim of mine is to improve outcome after stroke. We can test this by assessing whether individualised management plans provided to people with stroke will improve risk factors. Proper risk factor management reduces the risk of stroke recurrence. I also aim to reduce the burden of vascular disease in disadvantaged settings by finding out what risk factors are important in the development of these diseases in people living in poverty.